Barclays PLC Ark Genomic Revolution ETF (De Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Barclays PLC holds 15 shares of ARKG stock, worth $403. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15,601
99.9%
Holding current value
$403
Previous $379,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ARKG
# of Institutions
297Shares Held
20.3MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio